Albert Raises $55M to Scale Chemistry-Native AI
Albert, developer of the first chemistry-native AI operating system for R&D, announced a $55 million Series B funding.
Artificial Intelligence (AI)
Your Documents Stand up to Scrutiny. Does your AI?
Webinar: Defensible AI Answers for Regulated Decisions
Designing Materials: Why AI Is Becoming a Strategic Necessity
Chemicals firms face sustainability, supply-chain, and R&D pressures beyond slow trial-and-error. AI materials informatics, like Citrine Informatics, helps speed discovery. CEO Greg Mulholland on the market's evolution.
The Search Function: What AI Can't Replace in Biopharma Innovation
In AI-driven biopharma R&D, success means spotting outside innovation. CSL's Nishtha Jain on building AI platforms for external innovation, keeping human judgment central, and evolving leadership amid AI and ethics.
Why Reinvention Matters for the Chemical Industry
Chemical companies face rising volatility, weak demand and structural challenges. AI-powered reinvention can offer a path to faster growth, lower costs and greater competitiveness by transforming how work gets done.
Turning Expert Knowledge into a Growth Engine for Chemical Firms
Kimia codifies chemical experts’ unwritten knowledge into AI-ready answers. CEO Farid Mirmohseni explains how the startup turns scarce expertise into scalable growth.
Albert Launches First Chemistry-Native AI Built for Enterprise R&D
Albert recently announced Ask Albert, agentic chemistry-native AI built for enterprise R&D, designed to surface scientific knowledge and execute research tasks with accuracy and security.
Novo Nordisk Partners with Amazon to Boost Drug Discovery
Novo Nordisk and Amazon Web Services (AWS) have partnered to accelerate drug discovery with AI. A co-innovation hub in London will facilitate efforts to reduce the time to market for future medicines.
AkzoNobel accelerates R&D innovation with Albert Invent
AkzoNobel, a global leader in paints and coatings, and Albert Invent, who is building the future of chemistry R&D, recently announced an AI transformation partnership with AkzoNobel’s global R&D organization.
Citrine Launches Catalyst and Apex to Make AI Easier for Materials Scientists to Use and Trust
New capabilities help product development teams move from product goals to suggested experiments in minutes, with stronger predictive models behind the workflow.
Bayer and Iambic Partner to Advance AI-Driven Drug Discovery
Bayer and Iambic Therapeutics are collaborating to research new drugs using Iambic's AI-based platform. The collaboration focuses on the discovery of small molecules.
Advanced Polymer Coatings (APC) Collaborates with Albert Invent to Scale the Future of Modern R&D Infrastructure for Coatings
Advanced Polymer Coatings (APC), a global leader in polymer coatings, is making major strides in product development with chemistry AI company Albert Invent to advance and scale its modern R&D infrastructure.
Trusted Evidence in the Age of AI
AI in pharma has moved past the hype cycle and into implementation. The organizations that pull ahead won't have the most sophisticated models — they'll have the strongest evidence foundation underneath them.
Elevating AI-Driven Discovery: Simplifying Complexity with CDD Vault
Drug discovery generates enormous amounts of data, but turning it into meaningful insight is a major challenge.
Pharma 4.0: Big Promises, Poor Data - What’s Going Wrong?
Pharma 4.0 is high on every strategic agenda. Yet many struggle to turn digital ambitions into measurable results. Projects stall, systems don’t align, and valuable insights remain locked in fragmented data structures.
The Hidden Cost of How Chemical Companies Experiment
Smart Experimentation - why the combination of Design of Experiments and Bayesian Optimization with intuitive analytics is the most important productivity lever your R&D organization isn't using
Closing the Gap Between Lab and Production
Shorter development cycles and complex active ingredients are demanding integrated solutions. Guided by the principle "Together – from lab to production," Fette Compacting positions its R&D Solutions as a partnership.
AI as a Game Changer
How Artificial Intelligence is transforming the work of biotech and pharma companies.
Siemens and HighByte Target Fragmented Factory Data With Joint Infrastructure Play
Siemens and HighByte have joined forces to solve industrial data fragmentation. HighByte's Intelligence Hub connects OT and IT data sources to help manufacturers build and scale industrial AI applications.
INX Announces Strategic Collaboration with Albert Invent to Unlock AI-Powered Innovation Across its R&D Operations
INX International Ink, a leading global manufacturer of inks and coatings, and chemistry AI company Albert Invent recently announced a strategic collaboration to digitally transform INX’s R&D.
Sygnature Discovery Collaborates with DaltonTx to Advance AI-enabled Drug Discovery
Sygnature Discovery has partnered with AI firm DaltonTx to sharpen its drug discovery pipeline, bringing faster medicinal chemistry decisions and tighter data privacy to its CRO offering.
Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform
On-Demand | Explore how AI-driven materials informatics is reshaping polymer development, as industry leaders reveal practical strategies for scaling digital platforms and accelerating innovation.
The Successful Lab of The Future Requires Digital Transformation
As discovery accelerates and throughput rises, digital transformation is becoming essential for chemistry labs. AI, robotics, and data growth must be orchestrated to boost productivity—rather than overwhelm the lab.
2026 Predictions: AI and Regulation Reshape Biopharma R&D
AI and evolving regulations set to transform biopharma operations in drug development and quality.
Atomistic AI for Materials Engineering
Entalpic replaces trial‑and‑error materials R&D with a closed‑loop AI platform combining simulation and lab validation.
Aligning Artificial Intelligence and Laboratory Execution in Drug Discovery
From In Silico Design to In Vitro Impact
Syngenta Builds $130 Million Research Center for Agricultural Bioscience
New $130 million facility in Jealott’s Hill, UK, to focus on next-generation, sustainable solutions for farming.
Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy
Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.
Intelligent Flow Diagrams for the Digital Future
Inventory, significance and solutions for the process and chemical industry
Four Ways to Win amid Uncertainty
Strong Supply Chains, Efficiency, Digitalization, and Talent Development are Crucial for Chemical Distributors
Bridging the Sim2Real Gap in Materials
Dunia Innovations Merges AI and Robotics to Accelerate Real-World Materials Discovery
Lead or Lag: Europe’s AI Materials Race
How AI and Robotics are reshaping the race for materials discovery.
Digitalization in the Chemical Industry
Discover how digitalization is revolutionizing energy and resource efficiency in plant operation in the chemical industry.
Merck Awards Advance Biotech Prize to Biotech Start-up Neoclease
The award winner will receive access to Merck's technologies and expertise to expand its AI-based genome editing platform.
